300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in Europe (October 2023)

The most active venture capital funds investing in Europe Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Parkwalk Advisors
VC Fund
16 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $860k–$33M
Sofinnova Partners
VC Fund
15 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $4.4M–$57M
Oxford Science Enterprises
VC Fund
12 United Kingdom, United States, The Netherlands Seed, Series A Biotechnology, Health Care, Software $1M–$34M
UK Innovation & Science Seed Fund
VC Fund
12 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $246k–$10M
Kurma Partners
VC Fund
9 France, Spain, Switzerland Series A, Seed, Series B Health Care, Biotechnology, Medical $2.1M–$80M
Bpifrance
VC Fund
8 France, United States, Switzerland Seed, Series A Software, Health Care, Information Technology $643k–$29M
Seventure Partners
VC Fund
7 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $2.4M–$35M
24 Haymarket
VC Fund
7 United Kingdom, United States Seed, Series A Health Care, Software, Information Technology $1.2M–$16M
Archangels
VC Fund
7 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $123k–$7M
GM&C Life Sciences Fund
VC Fund
7 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $61k–$903k
Advent Life Sciences
VC Fund
6 United States, United Kingdom, France Series A, Series B Biotechnology, Health Care, Medical $2.5M–$75M
PMV
VC Fund
6 Belgium, The Netherlands, United States Series A, Seed Software, Biotechnology, Health Care $500k–$26M
Nina Capital
VC Fund
6 United States, United Kingdom, Austria Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Medical $573k–$21M
Selvedge Venture
VC Fund
6 United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Life Science $1.1M–$2.5M
Idinvest Partners
VC Fund
6 France, United States, Spain Series B, Series A Biotechnology, Software, Health Care $3.2M–$53M
Scottish Investment Bank
VC Fund
6 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Information Technology $307k–$7.6M
Angels in MedCity
VC Fund
6 United Kingdom, United States Seed, Angel Health Care, Biotechnology, Medical $614k–$774k
Development Bank of Wales
VC Fund
6 United Kingdom, Australia, United States Seed, Debt Financing Health Care, Software, Biotechnology $12k–$2.8M
Capital Cell
VC Fund
6 Spain, United States, United Kingdom Equity Crowdfunding, Seed Health Care, Biotechnology, Medical $134k–$1.9M
Newable Private Investing
VC Fund
6 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $184k–$3.8M
Enterprise Ireland
VC Fund
6 Ireland, United States, United Kingdom Seed, Series A Software, Health Care, Information Technology $429k–$12M
Epidarex Capital
VC Fund
5 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Therapeutics, Health Care $536k–$38M
Centre for the Development of Industrial Technology (CDTI)
VC Fund
5 Spain, United States, France Seed, Grant Biotechnology, Health Care, Software $123k–$4.4M
APEX Ventures
VC Fund
5 Germany, Austria, United Kingdom Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $643k–$16M
Amadeus Capital Partners
VC Fund
5 United Kingdom, United States, Spain Seed, Series B, Series A Software, Artificial Intelligence, Machine Learning $800k–$43M
Scottish Enterprise
VC Fund
5 United Kingdom, United States, Japan Grant, Seed Biotechnology, Software, Health Care $92k–$4.1M
R42 Group
VC Fund
5 United Kingdom, United States, Austria Seed, Pre-Seed, Series A Biotechnology, Health Care, Information Technology $429k–$15M
Omnes Capital
VC Fund
5 France, United States, Belgium Series A, Series B Software, Biotechnology, Health Care $3.2M–$37M
coparion
VC Fund
5 Germany, Switzerland, United States Series A, Seed, Series B Software, SaaS, FinTech $2M–$54M
Boehringer Ingelheim Venture Fund
VC Fund
5 United States, Germany, Belgium Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.3M–$50M
AIB Seed Capital Fund
VC Fund
5 Ireland, United States, Jersey Seed, Series A Software, Health Care, Medical $536k–$6.4M
IFB Innovationsstarter
VC Fund
5 Germany, United States Seed, Grant Software, SaaS, Artificial Intelligence $80k–$3M
Deepbridge Capital
VC Fund
5 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $143k–$10M
High-Tech Grunderfonds
VC Fund
5 Germany, Switzerland, United States Seed, Series A Software, Information Technology, Biotechnology $665k–$16M
Meusinvest (Noshaq)
VC Fund
4 Belgium, France, Germany Seed, Series A Health Care, Biotechnology, Medical $134k–$15M
O2h Ventures
VC Fund
4 United Kingdom, Hungary Seed, Series A, Pre-Seed Biotechnology, Health Care, Pharmaceutical $614k–$6.1M
Asabys Partners
VC Fund
4 Spain, Belgium, Germany Series A, Seed, Series B Biotechnology, Health Care, Medical Device $1.2M–$41M
Novo Holdings
VC Fund
4 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.5M–$125M
Roche Venture Fund
VC Fund
4 United States, United Kingdom, Spain Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $3.2M–$105M
Amino Collective
VC Fund
4 Germany, United States, United Kingdom Seed, Series A, Pre-Seed Health Care, Biotechnology, Software $2.9M–$6M
Angels 5K
VC Fund
4 United Kingdom Seed, Angel Biotechnology, Software, Medical $74k–$1.2M
SR One
VC Fund
4 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.7M–$85M
AlbionVC
VC Fund
4 United Kingdom, United States, France Series A, Seed Software, Health Care, Artificial Intelligence $1.8M–$13M
Techstart Ventures
VC Fund
4 United Kingdom, Ireland Seed, Pre-Seed Software, Health Care, Information Technology $86k–$2.5M
European Investment Bank
VC Fund
4 France, Germany, Ireland Debt Financing, Post-IPO Debt Biotechnology, Health Care, Software $6.4M–$536M
AdBio partners
VC Fund
4 France, Belgium, Spain Seed, Series A Biotechnology, Health Care, Pharmaceutical $2.1M–$29M
Verve Ventures
VC Fund
4 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $911k–$18M
11.2 Capital
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Software, Information Technology, Health Care $1M–$53M
Bullnet Capital
VC Fund
4 Spain, United States, Mexico Series A, Seed Software, Information Technology, Enterprise Software $3.2M–$3.2M
Fifty Years
VC Fund
4 United States, Germany, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $1.3M–$80M
Access all 50 VC funds in Europe Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 16 investments in Europe Life Science startups, 12 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 211
  • Round size: Seed $860k–$3.7M; Series A $1.5M–$12M; Series B $1.8M–$33M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 15 investments in Europe Life Science startups, 21 in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 12 investments in Europe Life Science startups, 15 in the past 12 months

Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 123
  • Round size: Seed $1M–$6.8M; Series A $3.7M–$34M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
  • AlveoGene — Welcome to AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy More information
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 12 investments in Europe Life Science startups, 13 in the past 12 months

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 96
  • Round size: Seed $246k–$2.9M; Series A $2.7M–$10M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
  • Pencil Biosciences — Next Generation Genome Editing Tool
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in Europe Life Science startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Spain, Switzerland

Investor stats

  • Total investments: 95
  • Round size: Seed $2.1M–$7.5M; Series A $2.1M–$50M; Series B $4.1M–$80M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: May invest from a new fund soon — raised $89M in 2020

Portfolio highlights

  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Show all investments...

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 8 investments in Europe Life Science startups, 117 in the past 12 months

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 667
  • Round size: Seed $643k–$5.4M; Series A $2M–$29M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
  • Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
  • Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 7 investments in Europe Life Science startups, 7 in the past 12 months

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 175
  • Round size: Series A $2.4M–$18M; Series B $3M–$35M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 7 investments in Europe Life Science startups, 6 in the past 12 months

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 95
  • Round size: Seed $1.2M–$3.7M; Series A $1.5M–$16M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • myGwork — The global recruitment & networking hub for LGBTQ+ professionals. Find jobs in lesbian, gay, bisexual and transgender friendly organisations. Grow your LGBTQ+ professional network. Read the latest LGBTQ+ professional news.
  • Previsico — Previsico is a spinOut company from Loughborough University specialising in modelling flooding in real-time, using weather predictions to make street-level flood nowcasts and forecasts. The company's mission is to be the leading global provider of cutting-edge flood prediction that saves lives and livelihoods.Its FloodMap Live producesround the clock street-level flood risk predictions and analytics. Uniquely, these are continuously modelled and updated using a combination of different weather forecasts. This allows the company to map the likelihood of short and long-term surface water events in real-time to the street level.
  • Huq Industries — The leading monitoring platform for footfall, dwell, catchment and traffic flows valued by government, retail and real-estate. Used by 50+ councils!
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 7 investments in Europe Life Science startups, 6 in the past 12 months

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $123k–$2.7M; Series A $1.5M–$7M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 7 investments in Europe Life Science startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 32
  • Round size: Seed $61k–$903k
  • Lead/follow: 69% lead, 31% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Advent Life Sciences
VC Fund · London, England, United Kingdom · 6 investments in Europe Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 58
  • Round size: Series A $2.5M–$25M; Series B $10M–$75M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
  • Tridek-One — Tridek-One is a private biotechnology company founded in 2018, based on groundbreaking research by our scientific founders at INSERM, Paris on the role of CD31 in the modulation of the immune response.
  • PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Show all investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 6 investments in Europe Life Science startups, 7 in the past 12 months

Do and dare company

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Seed
  • Geography: Belgium, The Netherlands, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $500k–$4.2M; Series A $2.1M–$26M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • IVEX — At IVEX, we are creating a safety co-pilot to make existing decision making platforms for autonomous driving safe. Our technology is based on years of research performed at KU Leuven University in Belgium. Our unique IP and team experience in behavior planning and functional safety enables the development of safe and reliable autonomous systems toreduce the traffic victims to zero by 2030.
  • Funkey — Kies je teambuilding uit meer dan 500 onvergetelijke activiteiten. Wij zorgen voor de volledige organisatie, incl. eventuele catering en overnachting.
  • dScribe — dScribe is your one-stop-shop to catalog, document and discover anything data-related.No more spending hours looking for the right data.No more doubting about the meaning of your KPIs.Reach the next level of data maturity by offering your users a single entry point to find, understand and access all your reports & data, no matter wherethey are stored.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 6 investments in Europe Life Science startups, 15 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Austria

Investor stats

  • Total investments: 58
  • Round size: Seed $1.2M–$6M; Pre-Seed $573k–$964k; Series A $5M–$21M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
  • Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
  • ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
Show all investments...

Selvedge Venture
VC Fund · London, England, United Kingdom · 6 investments in Europe Life Science startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 11
  • Round size: Seed $1.4M–$1.5M; Pre-Seed $1.1M–$2.5M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 6 investments in Europe Life Science startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 217
  • Round size: Series A $3.2M–$15M; Series B $7.4M–$53M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $86M in 2021

Portfolio highlights

  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • BreezoMeter — BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 6 investments in Europe Life Science startups

Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 195
  • Round size: Seed $307k–$2.5M; Series A $1.5M–$7.6M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 6 investments in Europe Life Science startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $614k–$774k
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Atelerix — The Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
  • DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 6 investments in Europe Life Science startups, 11 in the past 12 months

Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 149
  • Round size: Seed $307k–$1.8M; Debt Financing $12k–$2.8M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Stratigens — Talent intelligence software| external people analytics | Diversity, location planning and skills data to inform strategy | Data based decision making
  • 2B Enterprising — 2B Enterprising offers an enterprise education program for primary schools that aims to inspire next generation and foster an entrepreneurial mindset.
Show all investments...

Capital Cell
VC Fund · Barcelona, Catalonia, Spain · 6 investments in Europe Life Science startups

Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Equity Crowdfunding, Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 42
  • Round size: Seed $375k–$1.9M; Equity Crowdfunding $134k–$1.2M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
  • MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
  • Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 6 investments in Europe Life Science startups

Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $184k–$2.9M; Series A $1.2M–$3.8M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 6 investments in Europe Life Science startups, 19 in the past 12 months

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 383
  • Round size: Seed $429k–$2.9M; Series A $2M–$12M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
  • Tailr — Redefining production for the clothing industry.
  • Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 5 investments in Europe Life Science startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 39
  • Round size: Seed $536k–$8M; Series A $2M–$24M; Series B $2.4M–$38M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Transine Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

Centre for the Development of Industrial Technology (CDTI)
VC Fund · Madrid, Madrid, Spain · 5 investments in Europe Life Science startups, 13 in the past 12 months

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Grant
  • Geography: Spain, United States, France

Investor stats

  • Total investments: 106
  • Round size: Seed $536k–$4.4M; Grant $123k–$841k
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • inari — INARI provides blockchain, machine learning and artificial intelligence technologies for the Insurance industry
  • Candam — Candam is a technology company that provides innovative technological solutions for rewarding and refund of disposable waste.
  • wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 5 investments in Europe Life Science startups

APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Austria, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Seed $643k–$5.9M; Pre-Seed $643k–$1.7M; Series A $6M–$16M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
  • Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
  • Refined Laser Systems — Refined Laser Systems is a dynamic biophotonics company.It specialises in creating innovative laser systems for SRS-microscopy and quantum technology.
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in Europe Life Science startups, 7 in the past 12 months

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series B, Series A
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 197
  • Round size: Seed $800k–$7.5M; Series A $2M–$25M; Series B $6M–$43M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $86M in 2023

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
  • Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 5 investments in Europe Life Science startups, 24 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 193
  • Round size: Seed $197k–$2.9M; Grant $92k–$4.1M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • Rapscallion Soda — Award Winning, Fresh Fruit, Low Calorie Soft Drinks, Handmade in Scotland. Fresh batches made weekly. Free UK Mainland Delivery. International Shipping. Ginga Ninja | Burnt Lemon | Dry Lime | Scottish Rhubarb Soda | Scottish Strawberry Soda | Cranachan Soda | Blueberry Soda Love soda. Hate hangovers. Drink local.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 5 investments in Europe Life Science startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 23
  • Round size: Seed $614k–$4M; Pre-Seed $429k–$2M; Series A $4.2M–$15M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
  • KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
  • WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 5 investments in Europe Life Science startups, 9 in the past 12 months

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 152
  • Round size: Series A $3.2M–$21M; Series B $4M–$37M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $407M in 2020

Portfolio highlights

  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • The Exploration Company — For Space & Non-Space Industries.
Show all investments...

coparion
VC Fund · Cologne, Nordrhein-Westfalen, Germany · 5 investments in Europe Life Science startups, 6 in the past 12 months

Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 90
  • Round size: Seed $2M–$8.9M; Series A $4.5M–$14M; Series B $9.6M–$54M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
  • ContractHero — ContractHero is a leading digital contract management solution for business customers. The smart and easy-to-use software provides an overview of all current contracts, quickly identifies unnecessary costs and reduces risks from missed contract deadlines. As a result, companies have full control over their contracts and avoid missed deadlines andunnecessary costs.
  • Finanzguru — Finanzguru is an AI based financial assistant.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 5 investments in Europe Life Science startups

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Belgium

Investor stats

  • Total investments: 82
  • Round size: Seed $1.3M–$14M; Series A $3.8M–$29M; Series B $11M–$50M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
AIB Seed Capital Fund
VC Fund · Dublin, Dublin, Ireland · 5 investments in Europe Life Science startups

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Ireland, United States, Jersey

Investor stats

  • Total investments: 49
  • Round size: Seed $536k–$3.2M; Series A $1.1M–$6.4M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
Show all investments...

IFB Innovationsstarter
VC Fund · Hamburg, Hamburg, Germany · 5 investments in Europe Life Science startups

The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Seed, Grant
  • Geography: Germany, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $643k–$3M; Grant $80k–$161k
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • 3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
  • Stargazr — Stargazr is a AI-powered software that enables you to understand your financial data
  • Neuralfinity — Neuralfinity provides computer AI services. They generalise machine learning models by utilising an ML API as a service.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 5 investments in Europe Life Science startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 77
  • Round size: Seed $143k–$2.1M; Series A $1.8M–$10M
  • Lead/follow: 78% lead, 22% follow
  • Last fund: Likely still investing — raised $1.2M in 2022

Portfolio highlights

  • Circada — Innovative Circadian lighting reconnects the body clock with nature
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Show all investments...

High-Tech Grunderfonds
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 5 investments in Europe Life Science startups, 64 in the past 12 months

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 373
  • Round size: Seed $665k–$5.1M; Series A $1.5M–$16M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
  • Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 4 investments in Europe Life Science startups, 10 in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 54
  • Round size: Seed $134k–$4M; Series A $1.1M–$15M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • RISORCE — RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

O2h Ventures
VC Fund · 4 investments in Europe Life Science startups

Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 23
  • Round size: Seed $614k–$3.2M; Pre-Seed $1.7M–$2.5M; Series A $1.8M–$6.1M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Asabys Partners
VC Fund · Barcelona, Catalonia, Spain · 4 investments in Europe Life Science startups

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: Spain, Belgium, Germany

Investor stats

  • Total investments: 21
  • Round size: Seed $1.2M–$13M; Series A $4.4M–$32M; Series B $18M–$41M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — raised $107M in 2022

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Nuage Therapeutics — Nuage Therapeutics is a pharmaceutical company which utilizes chemical biology and biomolecular condensation to develop selective drugs that target proteins with disordered regions for challenging indications to improve patient’s life. The focus of the medication is to enhance selective inhibitors of intrinsically disordered proteins involved inchallenging indications in order to meet unmet medical needs.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 4 investments in Europe Life Science startups, 19 in the past 12 months

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 225
  • Round size: Series A $6.5M–$63M; Series B $12M–$125M; Series C $12M–$105M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Octave — Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
  • Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
  • Alentis Therapeutics — Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
Show all investments...

Roche Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 4 investments in Europe Life Science startups

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 107
  • Round size: Series A $4.8M–$42M; Series B $10M–$85M; Series C $3.2M–$105M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
  • Bonum Therapeutics — Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.
Show all investments...

Amino Collective
VC Fund · Berlin, Berlin, Germany · 4 investments in Europe Life Science startups

Amino Collective is an investment firm. They enable entrepreneurs and scientists to establish businesses that generate a better future for all species on Earth. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Seed $2.9M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
  • Enveda Biosciences — Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California.
  • Sensible Biotechnologies — Engineering cells to make better mRNA.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Angels 5K
VC Fund · Winchester, Hampshire, United Kingdom · 4 investments in Europe Life Science startups

Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $74k–$1.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
  • Novastone Media Ltd. — With its unique asymmetric technology, novastone puts you directly where your clients want to talk to you.
  • Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 4 investments in Europe Life Science startups, 8 in the past 12 months

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 154
  • Round size: Series A $3.7M–$40M; Series B $15M–$85M; Series C $27M–$57M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • Avalyn Pharma — This does NOT display on the home page
  • Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 4 investments in Europe Life Science startups, 10 in the past 12 months

AlbionVC supports visionary founders with long-term capital and scale-up expertise, and manages c. $1 billion of venture funds, invested in 50+ companies. AlbionVC is the technology investment arm of Albion Capital Group LLP. The technology team invest from seed through to Series B in high growth companies, predominantly in the UK. The team has a focus on B2B software and technology enabled services. AlbionVC %

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 119
  • Round size: Seed $1.8M–$13M; Series A $3.2M–$12M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • tem. — In a few simple steps we can manage your renewable energy needs forever.
  • Ramp Growth — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
Show all investments...

Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 4 investments in Europe Life Science startups, 7 in the past 12 months

Techstart Ventures is a leading investor of seed capital across Scotland and Northern Ireland. they are a trusted partner to ambitious founders on their journey to success.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland

Investor stats

  • Total investments: 121
  • Round size: Seed $154k–$2.5M; Pre-Seed $86k–$1.5M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Obbi Golf — Integrating Compliance, Safety and Quality across your Golf Club. Integrate greenkeepers, hospitality, pro shop and management.
  • loveelectric — loveelectric is on a mission to halve the cost of motoring
  • Desana — Seamlessly integrate existing assets into a global network of flexible workspaces and meeting rooms so staff can work from quality environments. Wherever.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 4 investments in Europe Life Science startups, 46 in the past 12 months

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, Ireland

Investor stats

  • Total investments: 190
  • Round size: Post-IPO Debt $6.4M–$536M; Debt Financing $11M–$321M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • ROCSYS — Meet the world's first autonomous charging solution for electrical vehicles in public transportation, logistics, material handling, and passenger cars.
  • Trucksters — We are a transportation company that focuses on providing long distance FTL trucking service through an innovative relay system based on artificial intelligence. We achieve transit times similar to air transport while reducing the costs of traditional road transportation.
  • Masdar Capital — Masdar Capital is developing & deploying commercial-scale renewable energy projects.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 4 investments in Europe Life Science startups, 6 in the past 12 months

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: France, Belgium, Spain

Investor stats

  • Total investments: 21
  • Round size: Seed $2.1M–$5.9M; Series A $20M–$29M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $106M in 2021

Portfolio highlights

  • Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Anoat Therapeutics — Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 4 investments in Europe Life Science startups, 16 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 200
  • Round size: Seed $911k–$5M; Series A $2.1M–$12M; Series B $4.1M–$18M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Show all investments...

11.2 Capital
VC Fund · San Francisco, California, United States · 4 investments in Europe Life Science startups

In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $1M–$4.6M; Series A $7.3M–$20M; Series B $40M–$53M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • Hubble Network — a Satellite network connecting billions of bluetooth devices. GLOBALLY.
  • Orbital Sidekick — Orbital Sidekick utilizes hyperspectral technology - capturing hundreds of narrow contiguous spectral bands, from visible light through infrared. The company develops a space-based infrastructure of hyperspectral sensors to provide monitoring services to the energy sector.Orbital Sidekick was founded in 2016 and is headquartered in San Francisco,California, United States.
Show all investments...

Bullnet Capital
VC Fund · Pozuelo De Alarcón, Madrid, Spain · 4 investments in Europe Life Science startups, 6 in the past 12 months

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Show more...

Investment focus

  • Industry: Software, Information Technology, Enterprise Software
  • Stage:Series A, Seed
  • Geography: Spain, United States, Mexico

Investor stats

  • Total investments: 36
  • Round size: Series A $3.2M–$3.2M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $45M in 2015

Portfolio highlights

  • Quside — Our QRNGs let innovators build advanced solutions for cybersecurity and computation.
  • wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
  • Deep Detection — Multispectral x-ray camera for food & beverage inspection
Show all investments...

Fifty Years
VC Fund · San Francisco, California, United States · 4 investments in Europe Life Science startups, 11 in the past 12 months

WE BACK HEROES using technology to solve the world's biggest problems

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 139
  • Round size: Seed $1.3M–$11M; Series A $6M–$30M; Series B $8.5M–$80M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
  • Elicit — Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Europe Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists